All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @fankams99 on TikTok · 31s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @fankams99's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Oh

@fankams99's Ozempic warning claims, fact-checked

fanKams

TikTok creator

16.7K viewsWatch on TikTok

Quick answer

GLP-1 receptor agonists like semaglutide work by mimicking hormones that regulate blood sugar and slow gastric emptying. Clinical trials show 14.9% average weight loss at 68 weeks with 2.4mg semaglutide. Most side effects are gastrointestinal and occur during the initial dose escalation period.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @fankams99's Ozempic warning claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@fankams99's Ozempic warning claims, fact-checked" from fanKams. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: GLP-1 receptor agonists like semaglutide work by mimicking hormones that regulate blood sugar and slow gastric emptying.

The reason this review is not generic is the source wording and the canonical claim label "glp1 idols lately been losing weight in a very concerning way so." In this clip, the useful excerpt is: "Oh" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Thyroid tumors appeared in animal studies but no confirmed human cases occurred during clinical trials
People who land here are usually trying to understand whether the Compounded Semaglutide claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

GLP-1 receptor agonists like semaglutide work by mimicking hormones that regulate blood sugar and slow gastric emptying.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • GLP-1 receptor agonists like semaglutide work by mimicking hormones that regulate blood sugar and slow gastric emptying. Clinical trials show 14.9% average weight loss at 68 weeks with 2.4mg semaglutide. Most side effects are gastrointestinal and occur during the initial dose escalation period.
  • Pancreatitis occurs in 0.2% of semaglutide patients versus 0.1% on placebo according to STEP trials
  • Thyroid tumors appeared in animal studies but no confirmed human cases occurred during clinical trials

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Pancreatitis occurs in 0.2% of semaglutide patients versus 0.1% on placebo according to STEP trials
  • Thyroid tumors appeared in animal studies but no confirmed human cases occurred during clinical trials
  • Most side effects are gastrointestinal: 44% experience nausea, 30% have diarrhea
  • Muscle loss with semaglutide is actually less than typical diet-only weight loss programs
  • NAION vision problems may be increased in diabetic patients but absolute risk remains very low
  • Kidney problems typically only occur with severe dehydration from untreated nausea/vomiting
  • Serious complications affect fewer than 1 in 500 patients in clinical trials

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this TikTok creator actually claim?

@fankams99 warns followers about Ozempic's dangers, listing five major risks: thyroid tumors/cancer, pancreatitis, kidney injury, vision problems, and muscle loss. The creator frames these as reasons to avoid the medication entirely.

The video targets young people concerned about celebrity weight loss trends. It presents these risks as definitive dangers rather than documented side effects with specific frequencies.

Does the science back up these warnings?

The listed side effects are real, but the creator doesn't mention how often they actually occur. The SUSTAIN trials (Marso et al., NEJM, 2016) found thyroid C-cell tumors in animal studies, but no confirmed cases in humans during clinical trials.

Pancreatitis occurred in 0.2% of semaglutide patients versus 0.1% on placebo in the STEP trials (Wilding et al., NEJM, 2021). That's a small absolute increase. Kidney problems typically happened only when patients became severely dehydrated from nausea and vomiting.

The vision claim refers to non-arteritic anterior ischemic optic neuropathy (NAION). A recent study (Hathaway et al., JAMA Ophthalmology, 2024) found higher NAION rates in diabetic patients taking semaglutide, but the absolute risk remains low.

What did the creator get wrong?

The biggest problem is presenting these as common, inevitable outcomes rather than rare side effects. Saying "here are some dangers" without context makes a 0.2% pancreatitis risk sound like a coin flip.

The muscle loss claim is particularly misleading. The STEP 1 trial showed patients lost about 39% of their weight from lean mass, which is actually better than typical diet-only weight loss where 25-30% comes from muscle.

@fankams99 also ignores that most of these risks apply specifically to people with diabetes or other medical conditions, not healthy individuals using the drug off-label.

What should you know about GLP-1 medication risks?

These medications do carry real risks, but they're generally rare and manageable. The most common side effects are gastrointestinal: nausea (44% of patients), diarrhea (30%), and vomiting (24%) in STEP trials.

Serious complications like pancreatitis happen in fewer than 1 in 500 patients. Kidney problems are usually preventable by staying hydrated during initial side effects.

The muscle loss concern is valid but overstated. Resistance training and adequate protein intake can help preserve muscle mass during weight loss, regardless of method.

Should this change how you think about Ozempic?

@fankams99's heart is in the right place, but the fear-mongering approach doesn't help anyone make informed decisions. These medications aren't candy, but they're not poison either.

The real issue isn't the drug's safety profile, which is well-established. It's people using prescription medications without proper medical supervision or understanding of the risks and benefits.

If you're considering GLP-1 medications, focus on whether you're a good candidate and whether you can commit to lifestyle changes that make the treatment effective long-term.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

fanKams · TikTok creator

16.7K views on this video

Idols lately been losing weight in a very concerning way, so I Wanted to remind every young girl (or boy) that this is not healthy at all, here are some dangers of the Ozempic medication: 1/Thyroid t

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about pancreatitis occurs in 0.2% of semaglutide patients versus 0.1% on?

Pancreatitis occurs in 0.2% of semaglutide patients versus 0.1% on placebo according to STEP trials

What does the video say about thyroid tumors appeared in animal studies?

Thyroid tumors appeared in animal studies but no confirmed human cases occurred during clinical trials

What does the video say about most side effects?

Most side effects are gastrointestinal: 44% experience nausea, 30% have diarrhea

What does the video say about muscle loss with semaglutide?

Muscle loss with semaglutide is actually less than typical diet-only weight loss programs

What does the video say about naion vision problems may be increased in diabetic patients?

NAION vision problems may be increased in diabetic patients but absolute risk remains very low

What does the video say about kidney problems typically only occur with severe dehydration from untreated?

Kidney problems typically only occur with severe dehydration from untreated nausea/vomiting

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by fanKams, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.